NCT04621461View on ClinicalTrials.gov

Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 20, 2020

Primary Completion Date

February 8, 2021

Study Completion Date

February 8, 2021

Conditions
Corona Virus Infection
Interventions
DIETARY_SUPPLEMENT

Zinc Sulfate 220 MG

220mg once daily for 5 days

DRUG

Placebo

Once daily for 5 days

Trial Locations (1)

11576

St. Francis Hospital - The Heart Center, Roslyn

All Listed Sponsors
lead

St. Francis Hospital, New York

OTHER

NCT04621461 - Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting | Biotech Hunter | Biotech Hunter